These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17504791)

  • 1. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
    Rios FG; Luna CM; Maskin B; Saenz Valiente A; Lloria M; Gando S; Sosa C; Baquero S; Llerena C; Petrati C; Apezteguia C
    Eur Respir J; 2007 Aug; 30(2):307-13. PubMed ID: 17504791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.
    Garnacho-Montero J; Ortiz-Leyba C; Jiménez-Jiménez FJ; Barrero-Almodóvar AE; García-Garmendia JL; Bernabeu-WittelI M; Gallego-Lara SL; Madrazo-Osuna J
    Clin Infect Dis; 2003 May; 36(9):1111-8. PubMed ID: 12715304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kallel H; Hergafi L; Bahloul M; Hakim A; Dammak H; Chelly H; Hamida CB; Chaari A; Rekik N; Bouaziz M
    Intensive Care Med; 2007 Jul; 33(7):1162-1167. PubMed ID: 17530220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
    Goyal K; Gautam V; Ray P
    Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures.
    Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC
    Int J Infect Dis; 2010 Aug; 14(8):e723-9. PubMed ID: 20542716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.
    Trouillet JL; Chastre J; Vuagnat A; Joly-Guillou ML; Combaux D; Dombret MC; Gibert C
    Am J Respir Crit Care Med; 1998 Feb; 157(2):531-9. PubMed ID: 9476869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
    Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
    Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventilator-associated pneumonia with Col-S strains: a successful comeback of colistin!
    Mukhopadhyay C; Krishna S; Vandana KE; Shenoy A; Bairy I
    Braz J Infect Dis; 2008 Oct; 12(5):444-6. PubMed ID: 19219287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
    Sathe P; Maddani S; Kulkarni S; Munshi N
    J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
    Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
    Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.